CT scans can play a role not just in diagnosing but also in monitoring non–cystic fibrosis bronchiectasis management, explained James D. Chalmers, MD. The use of CT scans is moving beyond a simple ...
Please provide your email address to receive an email when new articles are posted on . Treatment with brensocatib for 24 weeks significantly prolonged time to first pulmonary exacerbation in patients ...
The case suggests lung transplantation can be a feasible option for patients with lung involvement. A new case report is adding complexity to scientists’ understanding of a rare lysosomal storage ...
Treatment with the investigational anti-inflammatory drug brensocatib (formerly INS1007) significantly delayed the time to exacerbation in patients with the rare lung disease non-cystic fibrosis ...
Please provide your email address to receive an email when new articles are posted on . Brensocatib given as 10 mg or 25 mg performed better than placebo for three outcomes related to pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results